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Abstract Bcl2-associated athanogene 3 (BAG3) protein be-
longs to the family of co-chaperones interacting with several
heat shock proteins. It plays a key role in protein quality control
and mediates the clearance of misfolded proteins. Little is
known about the expression and cellular localization of
BAG3 during nervous system development and differentiation.
Therefore, we analyze the subcellular distribution and expres-
sion of BAG3 in nerve-growth-factor-induced neurite out-
growth in PC12 cells and in developing and adult cortex of
mouse brain. In differentiated PC12 cells, BAG3 was localized
mainly in the neuritic domain rather than the cell body, whereas
in control cells, it appeared to be confined to the cytoplasm near
the nuclear membrane. Interestingly, the change of BAG3 lo-
calization during neuronal differentiation was associated only
with a slight increase in total BAG3 expression. These data
were coroborated by transmission electron microscopy show-
ing that BAG3 was confined mainly within large dense-core
vesicles of the axon in differentiated PC12 cells. In mouse
developing cortex, BAG3 appeared to be intensely expressed
in cellular processes of migrating cells, whereas in adult brain, a
diffuse expression of low to medium intensity was detected in
neuronal cell bodies. These findings suggest that BAG3 expres-
sion is required for neuronal differentiation and migration and
that its role is linked to a change in its distribution pattern rather
than to an increase in its protein expression levels.
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Abbreviations
BAG3 Bcl2-associated athanogene 3
CNS Central nervous system
FGF Fibroblast growth factor
HSP Heat shock protein
LDCV Large dense-core vesicle
MTOC Microtubule organizer center
NGF Nerve growth factor
PLCγ Phosholipase C-γ
SCA3 Spinocerebellar ataxia type 3
SOD Superoxide dismutase
TEM Transmission electron microscopy
Introduction
Bcl2-associated athanogene 3 (BAG3) belongs to the family
of co-chaperones interacting with the ATPase domain of the
heat shock protein HSP70 through the structural domain
known as the BAG domain. BAG3 has a modular structure
also containing a WW domain and a proline-rich region
(PxxP) that mediates the binding to other proteins including
the SH3 domain containing phosholipase C-γ (PLCγ) and the
minus-end directed microtubule motor dynein (Arndt et al.
2010; Gamerdinger et al. 2011; Rosati et al. 2011). Two other
conserved IPV (Ile-Pro-Val) motifs have been identified; they
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are responsible for the interaction of BAG3with the small heat
shock protein HSPB8. The HSPB8-BAG3 complex is able to
induce macroautophagy and assist the autophagy-mediated
clearance of misfolded proteins including poliQ-expanded
huntingtin and mutated SOD1 proteins (Carra et al. 2008a;
Gamerdinger et al. 2011). Interestingly, BAG3 has been re-
ported to mediate the retrograde transport of both misfolded
proteins to the microtubule organizer center (MTOC) and au-
tophagic vacuoles to the perinuclear region, thus facilitating
the clearance of aggregated-prone proteins (Ravikumar et al.
2005; Carra et al. 2008b). In addition, in rat primary neurons,
BAG3 overexpression has been demonstrated to result in a
significant increase in the degradation of tau protein, a key neu-
ronal protein regulating cytoskeletal dynamics and synaptic func-
tion and implicated in the pathogenesis of Alzheimer’s disease
(Lei et al. 2015). In the central nervous system (CNS), BAG3
protein has been detected in reactive astrocytes from HIV-1-
associated encephalopathy biopsies and in human glial cells
and its expression appears to be modulated by several stress-
inducers including hypoxia-ischemia and viral infection (Rosati
et al. 2007; Bruno et al. 2014a). Seidel et al. (2012) demonstrated
that BAG3 expression levels are upregulated in astrocytes from
human brain tissues of patients with Alzheimer’s, Parkinson’s, or
spinocerebellar ataxia type 3 (SCA3) disease, whereas no signif-
icant variation of HSPB8-BAG3 expression has been found in
neurons of the same patients (Seidel et al. 2012). Of interest,
BAG3 has been observed to increase in neurons of rodent brain
during aging, together with an enhanced expression of
autophagosomal marker LC3-II (Gamerdinger et al. 2009).
These findings suggest that BAG3 is involved in neurodegener-
ative disease progression and its overexpression could be re-
quired during aging to compensate partially for the reduced ca-
pacity of the proteasomal-mediated degradation of misfolded
proteins (Keller et al. 2004; Li and Li 2011).
However, to date, only a few studies have addressed BAG3
distribution and function in the CNS. These studies have
shown that the protein presents a selective tissue distribution
pattern and that its expression, at the tissue and cellular levels,
is modified during development. Among them, some papers
reported BAG3 expression in rat CNS with a persistent ex-
pression in the rostral migratory stream and the subventricular
zone of the lateral ventricle and both a rapid and transient
increase of BAG3-positive neurons in the cortex and hippo-
campus during the first postnatal week (Choi et al. 2006).
More recent results indicate that BAG3 is expressed in adult
rat hippocampal neural progenitors in response to fibroblast
growth factor 2 (FGF2) treatment (Gentilella and Khalili
2010) and an early transient expression of BAG3 has been
observed in radial glia in the developing brainstem and spinal
cord of rats (Choi et al. 2009). However, no data have been
reported on the subcellular distribution of BAG3 in neurons,
although we have detected a molecular weight variant of
BAG3 (40 kDA) in synaptosomes of rat brain and provided
evidence that BAG3 mRNA is present in synaptosomal poly-
somes (Bruno et al. 2014b). Taken together, these consider-
ations suggest that BAG3 is involved in several specific neural
functions and participates in neuropathological processes.
Therefore, in order to provide further insights into the role of
BAG3 in neuronal differentiation and migration, we studied
BAG3 localization and expression in nerve growth factor
(NGF)-induced neurite outgrowth in the PC12 cell model
and examined the expression of BAG3 in the developing
and adult cerebral cortex of mice.
Materials and methods
Cell culture and NGF treatment
Rat pheochromocytoma PC12 cells were maintained in RPMI
1640Medium (Invitrogen, Italy) supplemented with 10% horse
serum (Invitrogen) and 5% fetal calf serum (Invitrogen) and
grown as monolayer cultures on Falcon dishes in a humidified
atmosphere at 37 °C and under 5% CO2. To induce the differ-
entiation of PC12 cells into neurons, cells were plated at a
concentration of 2 × 105/dish (100 mm plates, BD Falcon)
and cultured for 12 h. The cells were then divided into two
groups: the first did not receive treatment (untreated, controls),
whereas the secondwas treatedwith 100 ng/mlNGF (Sigma, St
Louis, Mo., USA). Cells received a medium change every
2 days and were treated every day with the same NGF concen-
tration as previously described (Levi-Montalcini 1987; Arisi
et al. 2014). To check cultures for their differentiation degree,
light microscope images of the living differentiating cells were
taken and neurite length was evaluated. Only cultures present-
ing cells with a neuritic length of at least 20 μm were destined
for imaging procedures. On the basis of the degree of differen-
tiation, we chose to perform immunofluorescence after 5 days
of NGF treatment. After two washes in phosphate buffer (PB),
cells were incubated in 4% paraformaldehyde/PB (Sigma) for
20 min followed by three washes in PB.
Animals and histological procedures
The following animals were used: three adult male mice
(C57BL/6 N; Harlan-Nossan, Correzzana, Italy) and three
mice at embryonic day 18 (E18; the day of vaginal plug dis-
covery in pregnant mothers was considered E0). Animal care
and experiments were conducted in conformity with Italian
and international laws and policies (EEC Council Directive
86/609, OJ L 358,1,12 December 1987; NIH Guide for the
Care and Use of Laboratory Animals, NIH Publication no.
85–23, 1985). The adult animals were transcardially perfused
under deep anesthesia (sodium pentobarbitol, 60 mg/kg, i.p.)
with 150 ml 0.9% saline at room temperature (RT) followed
by 200 ml 4% paraformaldehyde in 0.1 M PB at pH 7.4
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(PafPB). Brains were dissected, post-fixed for 2 h at room
tempertaure and after three washes in PB for 10 min,
cryoprotected in 30% PB/sucrose at 4 °C. Embryonic pups
were removed from the mothers, anesthetized by immersion
in dry ice and killed by decapitation followed by dissection of
their brains. Brains derived from embryonic pups were im-
mersed in PafPB for 24 h and from postnatal animals for
48 h. After three washes in PB of 10 min each, brains were
cryoprotected in 30% sucrose/PB at 4 °C. Once the brains had
soaked, they were frozen in dry ice and cut into 40-μm-thick
transverse sections on a sliding microtome. For adult animals,
one in every 10 sections was collected in PB, whereas for
embryonic and postnatal animals, one in every three sections
was collected for free-floating immunofluorescence proce-
dures. Qualitative inspections weremade of all the major brain
regions, whereas quantitative observations were confined to
the cerebral cortex. Boundaries and subdivisions were identi-
fied with reference to the atlas of Paxinos and Watson (2005).
Immunofluorescence and confocal microscopy
The following antibodies were used: mouse monoclonal anti-
BAG3 (1:400; AC-1, kindly provided by BIOUNIVERSA,
Salern, Italy); rabbit anti-β-tubulin III (1:200; Sigma); rabbit
monoclonal anti-neuronal nuclei (1:500; NeuN; Millipore) for
both tissue sections and cell cultures. Tissue sections were
incubated for 2 days at 4 °C in 0.3% Triton X-100/PB
(PBT) with a mix of the following primary antibodies: AC-
1/β-tubulin or AC-1/NeuN. After being washed in PBT, the
sections were incubated for 2 h at RT with Alexa-Fluor-488
donkey anti-rabbit IgG (1:200) and Alexa-Fluor-555 donkey
anti-mouse IgG (1:200).
Cell cultures were preincubated for 10 min in 0.1% PBT
and incubated overnight at 4 °C with a mix of the following
primary antibodies: AC-1/β-tubulin. After being washed with
PB, the cells were incubated for 1 h at RT with Alexa-Fluor-
488 donkey anti-rabbit IgG (1:500) and Alexa-Fluor-555 don-
key anti-mouse IgG (1:600). After two rinses in phosphate-
buffered saline (PBS), cells were treated for 10 min with a
4′,6-diamidino-2-phenylindole (DAPI; 1:500) solution
(Molecular Probes, Invitrogen) for visualization of nuclei.
Controls of both sections and cell cultures were processed
as above, except that the primary antibody was omitted or
substituted with nonspecific rabbit IgG. Both sections and cell
cultures were mounted on slides, coverslipped with mounting
gel and examined under a confocal laser scanning microscope
(Leica SP5, Leica Microsystems, Germany) under sequential
mode to avoid crosstalk among channels. Confocal image
acquisition was conducted so that all samples were imaged
by using consistent settings for pinhole aperture, laser power
and detector gain. Image processing and the preparation of the
final figures were carried out by using Adobe Photoshop 7 and
Adobe Illustrator 10.
Image analysis
Image analysis of anti-BAG3 (AC-1) confocal immunofluo-
rescence was performed by Imaris 7.4 (Bitplane) software as
previously described (Amadoro et al. 2014) on five different
images derived from three different cell culture replicates for
each experimental group. By using the transmitted light im-
ages showing the cellular profiles and those merged with the
immunofluorescence signal, a mask was manually drawn on
cells. Therefore, all the parameters were selectively evaluated
only on cellular profiles. Image analysis was performed under
visual control to determine thresholds; background noise was
subtracted and neuronal and vesicular structures were taken
into account. During image processing, the images were com-
pared with the raw data to make sure that no structures were
introduced or removed from the original data series.
Morphological parameters under analysis included immu-
nofluorescence intensity, number, area and colocalization of
vesicle-like structures, which were evaluated by using
Surface, Spots, and Coloc Imaris modules. To discriminate
between inner and outer cytoplasmic domains, another mask
was imposed on the cytoplasm and approximately divided the
cell into two halves: one juxtaposed to the cell membrane and
the other juxtaposed to the nucleus. To determine fluorescent
signal colocalization between the different channels, a median
filter was applied to reduce the background noise and the
degree of overlap was measured by Pearson’s coefficient,
which describes the relationship between the pixel intensities
of two channels by linear regression as previously described
(Nori et al. 2013).
Western blot analysis
Immunoprecipitation and Western blot analysis were per-
formed as previously described (Santoro et al. 2009; Bruno
et al. 2014a, 2014b). PC12 cells untreated or treated with NGF
were collected by centrifugation, washed twice with PBS and
resuspended in RIPA buffer (NaCl 150 mM, 1% Triton X-100
pH 8.0, 0.5% sodium deoxycholate, 0.1% SDS, 50MmTRIS,
pH 8.0) and 1× protease inhibitor cocktail (Sigma) for 30 min
on ice. Lysates were centrifuged at 4 °C and 15,000 rpm for
30 min. Supernatants were collected and the protein concen-
tration was determined by the Bradford protein assay. Equal
amounts of protein extracts (40 μg) were boiled in Laemmli’s
buffer, fractionated by 10% SDS-polyacrylamide gel electro-
phoresis and then transferred to nitrocellulose membranes
(Amersham, GE Healthcare). Membranes were blocked in
TBST (20 mM TRIS–HCl pH 7.4, 500 mM NaCl and
0.01% Tween-20) containing 10% non-fat dry milk, washed
in TBST and then incubated overnight at 4 °C with mouse
monoclonal anti-BAG3 (1:1000; AC-1). Anti-GAPDH (D-
glyceraldehyde-3-phosphate dehydrogenase) was used as
loading control (Cell Signalling). Blots were probed with
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mouse or rabbit secondary antibodies for 1 h and then devel-
oped by using an enhanced chemiluminescence (ECL) system
(Amersham, GEHealthcare).Western analysis was performed
at least three times and representative results are shown.
Electron microscopy
A cell monolayer was sequentially dehydrated in ascending
alcohols and infiltrated for 4 h at RTwith three changes of LR
white acrylic resin hard (Sigma). Coverslips were covered
with a cylindrical capsule filled with fresh LR white resin
and polymerized at 60 °C for 24 h. Thin sections were collect-
ed on 400-mesh nickel grids, incubated for 30 min at RT in
TBS blocking buffer (20 mM TRIS–HCl, pH 7.6, 225 mM
NaCl and 1% bovine serum albumin) containing 5% normal
goat serum and then incubated overnight at 4 °C with a poly-
clonal antibody recognizing primary monoclonal antibody
(AC-1, 8 ng/ml). After a 10-min washing step in TBS
blocking buffer, samples were incubated for 1 h at RT with
EM goat anti-mouse IgG 10 nm gold. Control grids were also
included in which the primary antibody was omitted. Sections
were stained with uranyl acetate and examined by means of a
JEOL 100S electron microscope (JEOL, Peabody, Mass.,
USA) operating at 80 kV.
Statistical analysis
Data were analyzed by GraphPad 5 software (GraphPad
Software, USA). Image analysis data were expressed as
means ± standard deviation (SD). Statistical differences be-
tween the treatments and the controls were evaluated by
one-way analysis of variance (ANOVA). In the case of a sig-
nificant result in the ANOVA, a two-tailed Student’s t test was
performed. Differences were considered statistically signifi-
cant when P < 0.05.
Results
BAG3 localization in differentiated PC12 cells
In order to investigate the localization and expression of
BAG3 protein during neuritic formation, we chose a cell mod-
el system partially resembling neuronal differentiation phe-
nomena. We used pheocromocytoma cells (PC12), a NGF-
responsive cell line derived from rat adrenal medulla. This cell
line is known to stop mitotic division and terminally differen-
tiate when treated with NGF (Levi-Montalcini 1987).
Immunofluorescence studies were performed both in NGF-
treated and NGF-untreated cultures. As shown in Fig. 1, after
NGF-induced neurite outgrowth, BAG3 localized in the neu-
ritic domain (Fig. 1a–d) and most of the immunoreactivity
seemed to be confined in granules resembling vesicular
structures. In undifferentiated PC12 cells, BAG3 protein was
expressed in the cell body (Fig. 1e–h) and the immunoreac-
tivity appeared to be densely packed and homogeneously dis-
tributed in the cytoplasm. From a qualitative point of view, in
NGF-stimulated cells, BAG3 expression in the cell body ap-
peared to be lower compared with that in untreated cells and
was located in the inner cytoplasmatic region, being virtually
absent in the outer cytoplasmatic region. In addition, in the
neuritic domain of NGF-stimulated cells, BAG3 expression
was higher than in the corresponding cell bodies. The BAG3
Fig. 1 Top Representative photomicrographs (a–h) of Bcl2-associated
athanogene 3 (BAG3) expression in PC12 cells after nerve growth factor
(NGF) priming (a–d) and in the basal condition (e–h). Confocal and
transmitted light (gray channel) images of double immunofluorescence
for BAG3 (red channel), β-tubulin III (green channel) and 4′,6-
diamidino-2-phenylindole (DAPI; blue channel). Note regions
containing BAG3-positive, loosely packed, granular structures (arrows,
see also inset) or barely detectable BAG3 immunopositivity
(arrowheads). Insets Neuritic region marked with an asterisk in a–d.
Bars 15 μm. Bottom left Representative Western blot of BAG3 in PC12
cells untreated (Control) or treated with NGF for 5 days (NGF). D-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a
loading control. Bottom right Densitometric analysis showing means in
arbitrary units (a.u.) and SD from three independent experiments
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immunoreactivity densely filled the neuritic domains and
colocalized with β-tubulin III, although a closer inspection
of higher magnification images (see insets in Fig. 1b, d)
showed that BAG3-immunopositive and β-tubulin-III-
negative dots were also evident suggesting a vesicular nature
of BAG3-immunopositive granules. This peculiar pattern dis-
tribution suggests that, following BAG3 production, the pro-
tein is immediately destined for the neurites where it shows
the highest expression.
To ascertain whether BAG3 expression could change dur-
ing NGF treatment, Western blot analysis was performed in
PC12 cells after the same treatment time and with the same
NGF concentration as used in the immunofluorescence anal-
ysis. The results (Fig. 1, bottom) indicated that no significant
variation of the BAG3 expression level occurred during PC12
cell differentiation, thus indicating that the subcellular locali-
zation of the protein changed during neuronal differentiation
but with no substantial increase in the protein expression level.
On the basis of the previous results, we estimated the dif-
ferent contributions of the segregated and total fraction of
BAG3 in the various cellular domains by performing morpho-
metric analysis of the total fluorescence and the fluorescence
of dots resembling vesicle-like structures, either in cell bodies
or in neuritic domains (Fig. 2). First, we measured the total
immunopositive cell area and fluorescence intensity in both
NGF-treated and untreated cells. As shown in Fig. 2a, b, stim-
ulation with NGF significantly increased the mean cell area
(166%), whereas only a slight and non-significant increase
was observed in cell fluorescence intensity in NGF-treated
cells compared with the controls (45%). Indeed, following
neuronal differentiation, the cell area, the vesicle-like structure
area and the vesicle number were different from the basal
condition, thus affecting the quantification of BAG3 expres-
sion by immunofluorescence. Therefore, we normalized the
fluorescence intensity against the measured cell area (Fig. 2c)
and the results showed that the mean amount of immunofluo-
rescence for cell area was higher in the control NGF-untreated
cells (72%) compared with treated cells (Fig. 2c vs a, b). This
finding suggests that the observed increase of cell fluores-
cence inNGF-treated cells is mainly attributable to the neuritic
domain.
Moreover, the separate evaluation of the vesicular-like
structures area and their fluorescence intensity, in both cellular
and neuritic domains of NGF-treated cells, showed a signifi-
cant increase of the mean area of these vesicular structures in
the cell bodies of NGF-stimulated cells versus controls (93%)
and in the neuritic domain versus the cell body domain of
NGF-treated (88%) and control (264%) cells (Fig. 2d). Data
concerning the fluorescence intensity of vesicle-like structures
in NGF-treated cells (Fig. 2e) showed a reduction of BAG3
fluorescence intensity in the cell bodies, together with an in-
crease in vesicle-like structure fluorescence of BAG3 in the
neuritic portion, suggesting that the expression of BAG3 was
higher in the neutites. Normalization of the fluorescence in-
tensity with the area of vesicle-like structures (Fig. 2f) re-
vealed that the detected protein intensity enhancement was
related to an increase in the area of neuritic granules. These
data obtained by quantitative image analysis were also in
agreement with Western analysis.
In cell bodies of the NGF-treated cells, BAG3 expression
was distributed particularly within the inner cytoplasmic do-
main (Fig. 1) leaving the outer cytoplasmic domain almost
completely devoid of BAG3 immunofluorescence. We quan-
tified this peculiar spatial distribution by evaluating the mean
number of immunopositive vesicle-like structures and their
distance from the cell membrane in NGF-treated and untreated
cell bodies. Measures reported in Fig. 2 (Fig. 2g, h) indicate a
general increase of the mean distance (46%) of BAG3-
immunopositive vesicular structures in NGF-stimulated cells
associated only with a modest increase of their mean total
number (7%). This result suggests that, also in the cell body,
BAG3 expression does not drastically change following NGF-
treatment but is redistributed. Although BAG3 and β-tubulin
were visually intimately associated (Fig. 1), the colocalization
index (Pearson’s coefficient, Fig. 2i) was not high in the two
groups. However, NGF-primed PC12 cells showed a higher
Pearson’s correlation coefficient with respect to the control
group indicating that BAG3 is also associated with the
cytoskeleton.
BAG3 localization in large dense-core vesicles
To investigate further the intriguing expression of BAG3 pro-
tein in NGF-induced PC12 cell differentiation, we analyzed
the subcellular localization of BAG3 by transmission electron
microscopy (TEM). After treatment with NGF, as carried out
for confocal microscopy analysis, cells were immunoreactive
to BAG3 antibody and BAG3 appeared to be distributed at
different morphological levels in the cell body (Fig. 3), where-
as in negative controls, no label was seen (data not shown). As
revealed in Fig. 3a, BAG3 was diffuse inside the nucleus and
in transition to the cytoplasm and was particularly detectable
inside the inner cytoplasmic areas with a granular texture.
Furthermore, BAG3 localized clearly into electron-dense ves-
icles clustered along the axon (Fig. 3b); these BAG3-positive
vesicles showed the typical aspects of large dense-core vesi-
cles (LDCVs).
BAG3 localization in developing and adult mouse brain
Since BAG3 expression was shown to be associated with
NGF-induced neuronal differentiation in PC12 cells, we de-
cided to investigate its expression in the developing (E18) and
adult brain. In the embryonal brain, BAG3 immunoreactivity
in the cortex was mainly distributed in the ventricular and
marginal zones where it appeared localized to filamentous
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structures organized in both the horizontal and the vertical
planes (Fig. 4a–d). Of note, several cells displayed intense
BAG3 immunofluorescence in the cell bodies and proximal
processes, suggesting that at least a part of the fluorescence
signal was ascribable to the cellular processes of cells that do
not reside in the confocal image acquisition plane. Some of
these intensely stained cells exhibited the typical bipolar mor-
phology of migrating cells (Nadarajah et al. 2003; Garcez
et al. 2015), with the cell body position and orientation either
on the tangential plane or on the radial plane and with a
straight and thin leading process.
In the adult cortex, however, we found a medium to low
diffuse expression of BAG3, both in NeuN-positive and
NeuN-negative cells (Fig. 4e–h), thus indicating the expres-
sion of BAG3 in neurons but probably also in glial cells. This
distribution pattern appeared to be widespread throughout the
brain with only slight regional variations.
Discussion
In the present study, we assessed the role of BAG3 in
neuronal development and showed that BAG3 is redistributed
during neuronal differentiation in vitro and is overexpressed
during neuronal migration in vivo. BAG3 protein is a member
of the BAG family, which plays a central role in cell protein
quality control and ubiquitin proteasome systems, two major
pathways that, together with the lysosomal degradation path-
way, are referred to as undertaking macroautophagy and that
regulate protein homeostasis and cytoskeletal remodeling
(Gamerdinger et al. 2011). To date, the increasing literature
has reported that BAG3 overexpression in glioma cells results
in the stimulation of autophagy (Merabova et al. 2015),
whereas in osteosarcoma and melanoma cells, it promotes cell
survival by sustaining the activation of NF-κB and preventing
IKKγ degradation (Ammirante et al. 2010; Rosati et al. 2011).
These observations suggest a complex regulative mechanism
of this protein that, because of its capacity to interact with very
different client proteins, could be involved in a variety of
biological processes from the balance of autophagy/
apoptosis to cell proliferation and differentiation. However,
few data are available concerning the physiological role of
BAG3 in the nervous system. In order to analyze BAG3 ex-
pression and localization during neuronal differentiation, we
used the rat pheochromocytoma cells PC12, which are a
well-known established in vitro model for studying neuronal
differentiation, proliferation and survival (Greene and Tischler
1976; Levi-Montalcini 1987). After stimulation with NGF,
these cells differentiate into neuron-like cells, which are
morphologically identifiable by cell hypertrophy and by the
Fig. 2 Image analysis of BAG3
confocal immunofluorescence in
PC12 cells untreated (white bars)
or treated (black bars) with NGF
for 5 days. Data are reported as
means and SD of three
independent experiments.
*P < 0.05; **P < 0.01 with the
Student’s t test. a–c Evaluation of
BAG3 expression in total cell area
of untreated and NGF-primed
cells. d–f Evaluation of
proportion of the vesicle-like
structures (Vesicles*) expressing
BAG3 in cell bodies (CB) and
neurites (N). g, h Estimation of
the immunopositive vesicle-like
structures (Vesicles*), namely
their number and their mean
distance (μm) from the cell
membrane in untreated and NGF-
treated cell bodies. i Pearson’s
coefficient was used as a
colocalization index of β-tubulin
III and BAG3; values from 0 to
0.5 indicate absence of
colocalization, whereas values
from 0.6 to 1.0 indicate
colocalization
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appearance of long neuritic processes of various calibers or-
ganized in a network.
Under our experimental conditions, dividing and non-
NGF-stimulated cells showed marked expression of BAG3
in densely packed granules of the cytosolic fraction, whereas
in NGF-treated cells, BAG3 appeared to be localized mainly
in vesicular-like structures that filled the neuritic domain.
Indeed, a medium to low immunofluorescence intensity of
BAG3 was also evident in the inner cytoplasm of NGF–
primed PC12 cells, suggesting that the protein might be stored
in cytoplasmic vesicles that thereafter migrate into neurites.
Morphometric andWestern blot analyses of BAG3 expression
corroborated this hypothesis, since the total amount of BAG3
immunofluorescence and the protein expression level were
not increased in NGF-treated cells compared with controls.
On the contrary, BAG3 immunoreactivity filled neurites and
increased in dots of the neuritic domain, being also partially
associated with β-tubulin, thus suggesting that BAG3 is lo-
cated in vesicles travelling along the cytoskeleton and is re-
quired to control the correct folding of neurite-specific pro-
teins and/or to direct protein-protein interactions during neu-
ritic formation. From this standpoint, our findings are in agree-
ment with the results of Lei et al. (2015) who provided evi-
dence of a tight correlation between the level of the tau pro-
tein, which is involved in cytoskeletal dynamics and synaptic
function and BAG3 expression in rat primary neurons.
Moreover, a physical interaction between cytoskeleton–regu-
lating proteins and BAG proteins has also been reported
(Ravikumar et al. 2005; Carrettiero et al. 2009). Of note, in
some cases, BAG3-positive beads could be identified in our
confocal microscopy images. Neuritic beads are thought to
represent degenerative structures in which the cellular cyto-
skeleton is collapsing (Takeuchi et al. 2005); however the
precise physiological significance of neuritic beading is still
unclear. One possibility is that BAG3 could have more than
one role, i.e., it may control protein folding and interaction
during neuritic formation and might stimulate the authophagy
process to favor the degradation of defective proteins in
degenerating or remodeling cytoskeletal structures. This is in
agreement with previously reported results showing that
BAG3 regulates macroautophagy pathways and is required
in stress conditions and during aging (Carra et al. 2008a,
2008b; Gamerdinger et al. 2009). Interestingly, our TEM
analysis confirmed our findings obtained by confocal micros-
copy and clearly show the localization of BAG3 in the
perinuclear region and in LDCVs of the axon. LDCVs are
known to store cathecolamine in PC12 cells (Dong et al.
2014) and therefore, we can hypothesize that BAG3 also plays
a role in catecholamine storage. We also found a weak BAG3
positivity inside the nucleus of differentiated PC12 cells but
the functional and molecular significance of this finding re-
mains to be explored.
In our study, we also analyzed BAG3 expression and dis-
tribution in the cortex of mouse brain. We showed that, in E18
embryos, BAG3 immunoreactivity was localized particularly
at the level of the ventricular and marginal zone in neurons
showing the typical features of migrating cells (Nadarajah
et al. 2003; Garcez et al. 2015), whereas in the adult brain, a
Fig. 3 Transmission electron micrographs of NGF-induced PC12 cell
differentiation showing localization of BAG3 (arrows) . a
Representative micrograph of cell body (N nucleus, NM nuclear mem-
brane). Bar 0.5 μm. b Representative micrograph of the cell axon (mt
mitochondrion). Bar 0.1 μm. PC12 cells showed rare BAG3
immunogold-labelled (10 nm) positivity in the nucleus and nucleolar
region (a), whereas BAG3 appeared more marked in the cytoplasm and
in large dense-core vesicles of the axon (b)
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lower BAG3 intensity appeared widespread in neuronal cell
bodies and in the neuropil. Of note, by using NeuN as a
marker of neurons, we showed that BAG3 was expressed
not only in neurons but also in glial cells identified as
NeuN-negative cells. This finding suggests that the protein
is expressed not only in astrocytes as previously reported
(Seidel et al. 2012) but also in oligodendrocytes and
microglia. However, this issue needs further investigations.
Our in vivo data are also in agreement with previous results
obtained by Choi et al. (2006) who provided evidence of
BAG3 immunoreactivity in the cerebral cortex of rat embryos
at the E18 stage and a reduction of BAG3 expression starting
from the 7th postnatal day (P7). The expression of BAG3 was
also studied by Park et al. (2003) who demonstrated selective-
ly BAG3-labeled cells in the subventricular zone of the lateral
ventricle of the adult rat brain (Park et al. 2003). However, to
analyze BAG3 distribution, these authors used a different
primary antibody (rabbit polyclonal anti-Bis antibody) detect-
ing BAG3 protein at its knownmolecular weight of 75 kDa. In
our study, we used a highly specific mouse monoclonal
antibody (AC-1) that was raised against a BAG3 N-terminal
peptide and that also recognizes different BAG3 protein species
with a lower molecular weight. From this point of view, Bruno
et al. (2008) previously demonstrated that, by using the tradition-
al BAG3 polyclonal antibody, a clear signal in total (cortex +
hippocampus) rat homogenate and in several subcellular frac-
tions can be observed, whereas the BAG3 signal is much less
evident in the synaptosomal fraction. However, when the same
authors used the AC-1 monoclonal antibody (the antibody that
we used), they were able to isolate BAG3 protein in
Fig. 4 BAG3 expression in the
developing (E18, a–d) and adult
cortex (2 months, e–h) of mouse
brain. Confocal images of double
immunofluorence for BAG3 (red
channel), β-Tubulin III (a–d,
green channel), NeuN (e–h,
green channel) and DAPI (blue
channel). BAG3 in the
developing cortex is intensely
expressed in cellular processes
and some migrating cells
(arrowheads). In the adult cortex,
low to medium immunoreactivity
is mainly found in the majority of
neuronal cell bodies (arrows) and
in some glial cells (arrowheads)
identified as non-NeuN-positive.
Bars 30 μm (a–d), 40 μm (e–h)
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synaptosomes, thus demonstrating that, in the synaptosomes of
rat brain, the shorter 40-kDa form of BAG3 possessing the N-
terminal region but lacking the C-terminal end is abundant. From
this viewpoint, the general more widespread CNS distribution
that we found compared with other authors might be attributable
to the expression of the different BAG3 forms recognized by our
antibody. This was also corroborated by the observation that, in
E18 and adult brain of rats, we obtained highly comparable re-
sults by using the same antibody (data not shown).Moreover, we
have to underline that Bruno et al. (2008) also provided evidence
that the shorter 40-kDa form of BAG3 seems particularly
expressed in cortex homogenates and we have demonstrated
elsewhere that it is possibly traduced by a dedicated mRNA also
present in synaptosomal polysomes of rat brain (Bruno et al.
2014a). On the basis of our microscopic analysis, we cannot
establish which form is predominant in neurons or whether a
differential expression of the BAG3 forms occurs in cell bodies
or neurites. However, in the present work, we demonstrated that,
in the adult cerebral cortex, BAG3 expression appears low but
more widespread than was previously thought and that this ex-
pression is compatible with a role for BAG3 in many different
neural functions. In addition, the finding that, in the embryonic
cerebral cortex, BAG3 is more intensely expressed suggests a
role in neuronal migration and differentiation.
In conclusion, our present findings, together with previous-
ly reported results, open new intriguing questions concerning
the possibility that the presence and differential expression of
BAG3 forms have other complementary or alternative func-
tions. Moreover, both BAG3 forms could be required for the
correct development of the nervous system and for the main-
tenance of protein homeostasis.
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